{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:38:20Z","timestamp":1785497900661,"version":"3.56.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH-NIAID","award":["R21AI175523"],"award-info":[{"award-number":["R21AI175523"]}]},{"name":"Carlos Slim Foundation via Baylor College of Medicine","award":["557608"],"award-info":[{"award-number":["557608"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01338-z","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T11:20:41Z","timestamp":1766056841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Randomized field trial of a therapeutic vaccine against Trypanosoma cruzi natural infection in dogs and correlates for efficacy"],"prefix":"10.1038","volume":"11","author":[{"given":"Jorge A.","family":"Calder\u00f3n-Quintal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F.","family":"Teh-Poot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landy M.","family":"Pech-Pist\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro P.","family":"Martinez-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Dzul-Huchim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Felipe","family":"Torres-Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Waleckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Villanueva-Lizama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Ortega-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dumonteil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Vladimir","family":"Cruz-Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"1338_CR1","doi-asserted-by":"publisher","unstructured":"Bern, C., Messenger, L. A., Whitman, J. D. & Maguire, J. H. Chagas disease in the United States: a public health approach. Clin. Microbiol. Rev. 33, https:\/\/doi.org\/10.1128\/CMR.00023-19 (2019).","DOI":"10.1128\/CMR.00023-19"},{"key":"1338_CR2","unstructured":"WHO. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Weekly Epidemiol. Rec. 90, 33\u201343 (2015)."},{"key":"1338_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","volume":"13","author":"BY Lee","year":"2013","unstructured":"Lee, B. Y., Bacon, K. M., Bottazzi, M. E. & Hotez, P. J. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect. Dis. 13, 342\u2013348 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"1338_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.prevetmed.2015.04.014","volume":"120","author":"R Castillo-Neyra","year":"2015","unstructured":"Castillo-Neyra, R. et al. The potential of canine sentinels for reemerging Trypanosoma cruzi transmission. Prev. Vet. Med. 120, 349\u2013356 (2015).","journal-title":"Prev. Vet. Med."},{"key":"1338_CR5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3201\/eid2008.131843","volume":"20","author":"TD Tenney","year":"2014","unstructured":"Tenney, T. D., Curtis-Robles, R., Snowden, K. F. & Hamer, S. A. Shelter dogs as sentinels for Trypanosoma cruzi transmission across Texas. Emerg. Infect. Dis. 20, 1323\u20131326 (2014).","journal-title":"Emerg. Infect. Dis."},{"key":"1338_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.actatropica.2006.05.006","volume":"98","author":"G Crisante","year":"2006","unstructured":"Crisante, G., Rojas, A., Teixeira, M. M. & Anez, N. Infected dogs as a risk factor in the transmission of human Trypanosoma cruzi infection in western Venezuela. Acta Trop. 98, 247\u2013254 (2006).","journal-title":"Acta Trop."},{"key":"1338_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1017\/S0031182006001259","volume":"134","author":"RE Gurtler","year":"2007","unstructured":"Gurtler, R. E. et al. Domestic dogs and cats as sources of Trypanosoma cruzi infection in rural northwestern Argentina. Parasitol 134, 69\u201382 (2007).","journal-title":"Parasitol"},{"key":"1338_CR8","first-page":"467","volume":"127","author":"ZA Andrade","year":"1987","unstructured":"Andrade, Z. A., Andrade, S. G. & Sadigursky, M. Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide. Am. J. Pathol. 127, 467\u2013473 (1987).","journal-title":"Am. J. Pathol."},{"key":"1338_CR9","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/jvim.12098","volume":"27","author":"AB Saunders","year":"2013","unstructured":"Saunders, A. B. et al. Bradyarrhythmias and pacemaker therapy in dogs with Chagas disease. J. Vet. Int. Med. 27, 890\u2013894 (2013).","journal-title":"J. Vet. Int. Med."},{"key":"1338_CR10","volume":"24","author":"AC Meyers","year":"2021","unstructured":"Meyers, A. C., Edwards, E. E., Sanders, J. P., Saunders, A. B. & Hamer, S. A. Fatal Chagas myocarditis in government working dogs in the southern United States: cross-reactivity and differential diagnoses in five cases across six months. Vet. Parasitol. Reg. Stud. Rep. 24, 100545 (2021).","journal-title":"Vet. Parasitol. Reg. Stud. Rep."},{"key":"1338_CR11","doi-asserted-by":"publisher","first-page":"e0005819","DOI":"10.1371\/journal.pntd.0005819","volume":"11","author":"AC Meyers","year":"2017","unstructured":"Meyers, A. C., Meinders, M. & Hamer, S. A. Widespread Trypanosoma cruzi infection in government working dogs along the Texas-Mexico border: discordant serology, parasite genotyping and associated vectors. PLoS Negl. Trop. Dis. 11, e0005819 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1338_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.vetpar.2009.02.024","volume":"162","author":"JV Cruz-Chan","year":"2009","unstructured":"Cruz-Chan, J. V. et al. Immunopathology of natural Trypanosoma cruzi infection in dogs. Vet. Parasitol. 162, 151\u2013155 (2009).","journal-title":"Vet. Parasitol."},{"key":"1338_CR13","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/cid\/civ230","volume":"60","author":"S Antinori","year":"2015","unstructured":"Antinori, S. et al. High frequency of adverse reactions and discontinuation with benznidazole treatment for chronic Chagas disease in Milano, Italy. Clin. Infect. Dis. 60, 1873\u20131875 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"1338_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1191\/0960327106het653oa","volume":"25","author":"JA Castro","year":"2006","unstructured":"Castro, J. A., de Mecca, M. M. & Bartel, L. C. Toxic side effects of drugs used to treat Chagas\u2019 disease (American trypanosomiasis). Hum. Exp. Toxicol. 25, 471\u2013479 (2006).","journal-title":"Hum. Exp. Toxicol."},{"key":"1338_CR15","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1086\/656917","volume":"51","author":"Y Jackson","year":"2010","unstructured":"Jackson, Y. et al. Tolerance and safety of nifurtimox in patients with chronic Chagas disease. Clin. Infect. Dis. 51, e69\u2013e75 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"1338_CR16","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1128\/AAC.00537-10","volume":"54","author":"MJ Pinazo","year":"2010","unstructured":"Pinazo, M. J. et al. Tolerance of benznidazole in treatment of Chagas\u2019 disease in adults. Antimicrobial Agents Chemother. 54, 4896\u20134899 (2010).","journal-title":"Antimicrobial Agents Chemother."},{"key":"1338_CR17","doi-asserted-by":"publisher","unstructured":"Dumonteil, E. & Herrera, C. The case for the development of a Chagas disease vaccine: Why? How? When? Trop. Med. Infect. Dis. 6, https:\/\/doi.org\/10.3390\/tropicalmed6010016 (2021).","DOI":"10.3390\/tropicalmed6010016"},{"key":"1338_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/erv.12.85","volume":"11","author":"E Dumonteil","year":"2012","unstructured":"Dumonteil, E. et al. Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects. Expert Rev. Vaccines 11, 1043\u20131055 (2012).","journal-title":"Expert Rev. Vaccines"},{"key":"1338_CR19","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.4161\/hv.20966","volume":"8","author":"BY Lee","year":"2012","unstructured":"Lee, B. Y. et al. Modeling the economic value of a Chagas\u2019 Disease therapeutic vaccine. Hum. Vaccines Immunother. 8, 1293\u20131301 (2012).","journal-title":"Hum. Vaccines Immunother."},{"key":"1338_CR20","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1093\/eurheartj\/ehz283","volume":"40","author":"E Lutgens","year":"2019","unstructured":"Lutgens, E. et al. Immunotherapy for cardiovascular disease. Eur. Heart J. 40, 3937\u20133946 (2019).","journal-title":"Eur. Heart J."},{"key":"1338_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1128\/IAI.72.1.46-53.2004","volume":"72","author":"E Dumonteil","year":"2004","unstructured":"Dumonteil, E., Escobedo-Ortegon, J., Reyes-Rodriguez, N., Ramirez-Sierra, M. J. & Arjona-Torres, A. Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice. Infect. Immun. 72, 46\u201353 (2004).","journal-title":"Infect. Immun."},{"key":"1338_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/21645515.2018.1520581","volume":"15","author":"JJ de la Cruz","year":"2019","unstructured":"de la Cruz, J. J. et al. Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice. Hum. Vaccines Immunother. 15, 210\u2013219 (2019).","journal-title":"Hum. Vaccines Immunother."},{"key":"1338_CR23","doi-asserted-by":"publisher","first-page":"e0007413","DOI":"10.1371\/journal.pntd.0007413","volume":"13","author":"MA Barry","year":"2019","unstructured":"Barry, M. A. et al. A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection. PLoS Negl. Trop. Dis. 13, e0007413 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1338_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1080\/21645515.2015.1119346","volume":"12","author":"MA Barry","year":"2016","unstructured":"Barry, M. A. et al. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB\/c mouse model of Chagas disease. Hum. Vaccines Immunother. 12, 976\u2013987 (2016).","journal-title":"Hum. Vaccines Immunother."},{"key":"1338_CR25","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1016\/j.vaccine.2015.07.017","volume":"33","author":"V Martinez-Campos","year":"2015","unstructured":"Martinez-Campos, V. et al. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice. Vaccine 33, 4505\u20134512 (2015).","journal-title":"Vaccine"},{"key":"1338_CR26","doi-asserted-by":"publisher","first-page":"7414","DOI":"10.1016\/j.vaccine.2010.08.104","volume":"28","author":"AY Limon-Flores","year":"2010","unstructured":"Limon-Flores, A. Y. et al. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells. Vaccine 28, 7414\u20137419 (2010).","journal-title":"Vaccine"},{"key":"1338_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.imlet.2005.11.015","volume":"103","author":"H Zapata-Estrella","year":"2006","unstructured":"Zapata-Estrella, H. et al. Control of Trypanosoma cruzi infection and changes in T cell populations induced by a therapeutic DNA vaccine in mice. Immunol. Lett. 103, 186\u2013191 (2006).","journal-title":"Immunol. Lett."},{"key":"1338_CR28","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/14760584.2022.2093721","volume":"21","author":"KM Jones","year":"2022","unstructured":"Jones, K. M., Poveda, C., Versteeg, L., Bottazzi, M. E. & Hotez, P. J. Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine. Exp. Rev. Vaccines 21, 1185\u20131203 (2022).","journal-title":"Exp. Rev. Vaccines"},{"key":"1338_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82930-w","volume":"11","author":"JV Cruz-Chan","year":"2021","unstructured":"Cruz-Chan, J. V. et al. Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection. Sci. Rep. 11, 3222 (2021).","journal-title":"Sci. Rep."},{"key":"1338_CR30","doi-asserted-by":"publisher","unstructured":"Jones, K. et al. Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease. Infect & Immun 86, https:\/\/doi.org\/10.1128\/IAI.00876-17 (2018).","DOI":"10.1128\/IAI.00876-17"},{"key":"1338_CR31","doi-asserted-by":"publisher","first-page":"e0010258","DOI":"10.1371\/journal.pntd.0010258","volume":"16","author":"VM Dzul-Huchim","year":"2022","unstructured":"Dzul-Huchim, V. M. et al. Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB\/c mice. PLoS Negl. Trop. Dis. 16, e0010258 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1338_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/vbz.2018.2325","volume":"19","author":"BL Travi","year":"2019","unstructured":"Travi, B. L. Considering dogs as complementary targets of Chagas disease control. Vector Borne Zoonotic Dis. 19, 90\u201394 (2019).","journal-title":"Vector Borne Zoonotic Dis."},{"key":"1338_CR33","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1016\/j.vaccine.2013.03.005","volume":"31","author":"IA Quijano-Hernandez","year":"2013","unstructured":"Quijano-Hernandez, I. A. et al. Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi. Vaccine 31, 2246\u20132252 (2013).","journal-title":"Vaccine"},{"key":"1338_CR34","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1111\/eva.13068","volume":"13","author":"A Arnal","year":"2020","unstructured":"Arnal, A., Villanueva-Lizama, L., Teh-Poot, C., Herrera, C. & Dumonteil, E. Extent of polymorphism and selection pressure on the Trypanosoma cruzi vaccine candidate antigen Tc24. Evol. Appl. 13, 2663\u20132672 (2020).","journal-title":"Evol. Appl."},{"key":"1338_CR35","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/pim.12130","volume":"36","author":"JM Knight","year":"2014","unstructured":"Knight, J. M., Zingales, B., Bottazzi, M. E., Hotez, P. & Zhan, B. Limited antigenic variation in the Trypanosoma cruzi candidate vaccine antigen TSA-1. Parasite Immunol. 36, 708\u2013712 (2014).","journal-title":"Parasite Immunol."},{"key":"1338_CR36","doi-asserted-by":"crossref","unstructured":"Carlier, Y. et al. Coinfection by multiple Trypanosoma cruzi clones: a new perspective on host-parasite relationship with consequences for pathogenesis and management of Chagas disease. Microbiol. Mol. Biol. Rev. 89, e0024224 (2025).","DOI":"10.1128\/mmbr.00242-24"},{"key":"1338_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92176-5","volume":"15","author":"JA Calder\u00f3n-Quintal","year":"2025","unstructured":"Calder\u00f3n-Quintal, J. A. et al. Natural infection of Trypanosoma cruzi in client-owned-dogs from rural Yucatan, Mexico. Sci. Rep. 15, 10263 (2025).","journal-title":"Sci. Rep."},{"key":"1338_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04236-22","volume":"11","author":"E Dumonteil","year":"2023","unstructured":"Dumonteil, E. et al. Intra-host Trypanosoma cruzi strain dynamics shape disease progression: the missing link in Chagas disease pathogenesis. Microbiol Spectr. 11, e0423622 (2023).","journal-title":"Microbiol Spectr."},{"key":"1338_CR39","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1016\/j.vaccine.2020.05.010","volume":"38","author":"E Dumonteil","year":"2020","unstructured":"Dumonteil, E. et al. Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques. Vaccine 38, 4584\u20134591 (2020).","journal-title":"Vaccine"},{"key":"1338_CR40","doi-asserted-by":"publisher","unstructured":"Calderon-Quintal, J. A. et al. Randomized field trial of a therapeutic vaccine against Trypanosoma cruzi natural infection in dogs and correlates for efficacy. bioRxiv https:\/\/doi.org\/10.1101\/2025.05.12.653529 (2025).","DOI":"10.1101\/2025.05.12.653529"},{"key":"1338_CR41","doi-asserted-by":"publisher","first-page":"e0007902","DOI":"10.1371\/journal.pntd.0007902","volume":"13","author":"A Flores-Ferrer","year":"2019","unstructured":"Flores-Ferrer, A., Waleckx, E., Rascalou, G., Dumonteil, E. & Gourbi\u00e8re, S. Trypanosoma cruzi transmission dynamics in a synanthropic and domesticated host community. PLoS Negl. Trop. Dis. 13, e0007902 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1338_CR42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/jvim.15352","volume":"33","author":"CL Hodo","year":"2019","unstructured":"Hodo, C. L. et al. Repeated cross-sectional study of Trypanosoma cruzi in shelter dogs in Texas, in the context of Dirofilaria immitis and tick-borne pathogen prevalence. J. Vet. Int. Med. 33, 158\u2013166 (2019).","journal-title":"J. Vet. Int. Med."},{"key":"1338_CR43","doi-asserted-by":"publisher","first-page":"e1004594","DOI":"10.1371\/journal.ppat.1004594","volume":"11","author":"IR Pereira","year":"2015","unstructured":"Pereira, I. R. et al. A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy. PLoS Pathog. 11, e1004594 (2015).","journal-title":"PLoS Pathog."},{"key":"1338_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12929-025-01152-8","volume":"32","author":"RM Clear","year":"2025","unstructured":"Clear, R. M. et al. Association of antibody and T cell receptor repertoires in Trypanosoma cruzi infected rhesus macaques and host response to infection. J. Biomed. Sci. 32, 58 (2025).","journal-title":"J. Biomed. Sci."},{"key":"1338_CR45","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1338_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/imr.13142","volume":"314","author":"L Kalafati","year":"2023","unstructured":"Kalafati, L., Hatzioannou, A., Hajishengallis, G. & Chavakis, T. The role of neutrophils in trained immunity. Immunol. Rev. 314, 142\u2013157 (2023).","journal-title":"Immunol. Rev."},{"key":"1338_CR47","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1016\/j.cell.2021.05.039","volume":"184","author":"F Wimmers","year":"2021","unstructured":"Wimmers, F. et al. The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination. Cell 184, 3915\u20133935 e3921 (2021).","journal-title":"Cell"},{"key":"1338_CR48","doi-asserted-by":"publisher","first-page":"e186003","DOI":"10.1172\/jci.insight.186003","volume":"10","author":"H Desale","year":"2025","unstructured":"Desale, H. et al. PBMC transcriptomic signatures reflect Trypanosoma cruzi strain diversity and trained immunity in chronically infected macaques. JCI Insight 10, e186003 (2025).","journal-title":"JCI Insight"},{"key":"1338_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/infdis\/jiw540","volume":"215","author":"LR Ferreira","year":"2017","unstructured":"Ferreira, L. R. et al. Blood gene signatures of Chagas cardiomyopathy with or without ventricular dysfunction. J. Infect. Dis. 215, 387\u2013395 (2017).","journal-title":"J. Infect. Dis."},{"key":"1338_CR50","doi-asserted-by":"publisher","first-page":"706583","DOI":"10.3389\/fimmu.2021.706583","volume":"12","author":"DM Murphy","year":"2021","unstructured":"Murphy, D. M., Mills, K. H. G. & Basdeo, S. A. The effects of trained innate immunity on T cell responses; clinical implications and knowledge gaps for future research. Front Immunol. 12, 706583 (2021).","journal-title":"Front Immunol."},{"key":"1338_CR51","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4049\/jimmunol.2300509","volume":"212","author":"AL Horta","year":"2024","unstructured":"Horta, A. L. et al. Memory-like NK cells are a critical component of vaccine-induced immunity to Trypanosoma cruzi infection. J. Immunol. 212, 617\u2013631 (2024).","journal-title":"J. Immunol."},{"key":"1338_CR52","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).","journal-title":"PLoS Biol."},{"key":"1338_CR53","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/21645515.2016.1242540","volume":"13","author":"CA Seid","year":"2017","unstructured":"Seid, C. A. et al. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human Chagas disease. Hum. Vaccines Immunother. 13, 621\u2013633 (2017).","journal-title":"Hum. Vaccines Immunother."},{"key":"1338_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-020-00972-1","volume":"17","author":"ML Cafferata","year":"2020","unstructured":"Cafferata, M. L. et al. Short-course Benznidazole treatment to reduce Trypanosoma cruzi parasitic load in women of reproductive age (BETTY): a non-inferiority randomized controlled trial study protocol. Reprod. Health 17, 128 (2020).","journal-title":"Reprod. Health"},{"key":"1338_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1338_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2486-6","volume":"19","author":"SX Ge","year":"2018","unstructured":"Ge, S. X., Son, E. W. & Yao, R. iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinforma. 19, 534 (2018).","journal-title":"BMC Bioinforma."},{"key":"1338_CR57","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2628\u20132629 (2020).","journal-title":"Bioinformatics"},{"key":"1338_CR58","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1093\/bioinformatics\/btm369","volume":"23","author":"A Subramanian","year":"2007","unstructured":"Subramanian, A., Kuehn, H., Gould, J., Tamayo, P. & Mesirov, J. P. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23, 3251\u20133253 (2007).","journal-title":"Bioinformatics"},{"key":"1338_CR59","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Nat. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"1338_CR60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.2789","volume":"15","author":"S Li","year":"2014","unstructured":"Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15, 195\u2013204 (2014).","journal-title":"Nat. Immunol."},{"key":"1338_CR61","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12929-024-01050-5","volume":"31","author":"E Dumonteil","year":"2024","unstructured":"Dumonteil, E. et al. Immunoglobulin and T cell receptor repertoire changes induced by a prototype vaccine against Chagas disease in naive rhesus macaques. J. Biomed. Sci. 31, 58 (2024).","journal-title":"J. Biomed. Sci."},{"key":"1338_CR62","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/978-1-61779-842-9_32","volume":"882","author":"E Alamyar","year":"2012","unstructured":"Alamyar, E., Duroux, P., Lefranc, M. P. & Giudicelli, V. IMGT((R)) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT\/V-QUEST and IMGT\/HighV-QUEST for NGS. Methods Mol. Biol. 882, 569\u2013604 (2012).","journal-title":"Methods Mol. Biol."},{"key":"1338_CR63","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fimmu.2016.00339","volume":"7","author":"S Aouinti","year":"2016","unstructured":"Aouinti, S. et al. IMGT\/StatClonotype for pairwise evaluation and visualization of NGS IG and TR IMGT clonotype (AA) diversity or expression from IMGT\/HighV-QUEST. Front Immunol. 7, 339 (2016).","journal-title":"Front Immunol."},{"key":"1338_CR64","unstructured":"Magurran, A. E. Mesuring Biological Diversity (Blackwell Science Ltd, 2004)."},{"key":"1338_CR65","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jmii.2022.09.003","volume":"56","author":"E Dumonteil","year":"2023","unstructured":"Dumonteil, E., Herrera, C. & Marx, P. A. Safety and preservation of cardiac function following therapeutic vaccination against Trypanosoma cruzi in rhesus macaques. J. Microbiol Immunol. Infect. 56, 400\u2013407 (2023).","journal-title":"J. Microbiol Immunol. Infect."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01338-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:04:21Z","timestamp":1769007861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01338-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1338"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01338-z","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}